Patent ID: 11905295
Assignee: TERRAN BIOSCIENCES INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 16:
17. A solid form of tabernanthalog monofumarate salt of the following formula:, wherein the solid form is crystalline polymorphic Pattern #6a;
wherein crystalline polymorphic Pattern #6a is characterized by an X-ray powder diffraction diffractogram comprising two signals at angles (°2θ) selected from the group consisting of 16.6°±0.2 °2θ, 19.6°±0.2 °2θ, and 20.7°±0.2 °2θ; and
wherein the X-ray powder diffraction diffractogram signals are present when the X-ray powder diffraction is carried out using Cu Kα1 radiation.